Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2025-12-24 @ 10:40 PM
NCT ID:
NCT01519635
Eligibility Criteria:
Inclusion Criteria:
* Tolerance to study drugs
* Age \> 18 years
* Arteria hypertension stage 1-2 (blood pressure: 140/90 and 180/110 mm Hg)
* Normal renal function
* Availability to give informed consent
Exclusion Criteria:
* Intolerance to study drugs
* Renal artery stenosis
* Hyperkalaemia \> 5.0 mmol/l
* Contra-indications to the use of PAH, inulin or Lithium
* Asthma
* Pychiatric illness
* No estimated easy vascular venous access for placement of two peripherical venous catheters in forearms
* Contra-indication to MRI-imaging: Claustrophobia or Pacemaker or other implanted metal device
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01519635
Study Brief:
Protocol Section:
NCT01519635